Home2018-10-09T07:01:36+00:00

Balanced lifestyle for brain health

Find out more

About NEUROLANCE

Neurolance is developing a state-of-the-art, software based intervention clinic against Alzheimer’s Disease. At risk and diagnosed clients will spend 8 – 12 weeks participating in our Zurich – Switzerland based outpatient treatment program. In collaboration with global partners, the clinical protocols will be continuously monitored and updated against preclinical Alzheimer’s and Dementia screening.

 ALLIANCES & COLLABORATIONS

Alzheimer’s Disease and Dementia are Growing Problems

OUR NOVEL PREVENTION TREATMENT

The timing is urgent for clinicians to use positive behavioural techniques to measure, motivate, and strategize. To increase compliance with new neuroscience associated with driving neuroplasticity in a positive direction.

DIGITAL HEALTH

Altoida has developed an early screening methodology based on longitudinal clinical studies with more than 2700 Alzheimer’s Disease (AD) patients over a period of 8 years. The Altoida app tracks neuroprotection and can reveal risk factors for developing Alzheimer within 6 years with an accuracy of 94%. Monthly cognitive outcomes assessed by patent pending technology measures everyday function with 250 features at a sampling rate of 300 Hz (Neuro Motor Index). Neurolance plans to work closely with Altoida in order to identify its presymptomatic at risk population

TEAM

LEARN MORE

FACILITY

LEARN MORE

INVESTOR RELATIONS

LEARN MORE

CONTACT US